JPMorgan Chase & Co’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $465K | Sell |
135,441
-68,812
| -34% | -$236K | ﹤0.01% | 4100 |
|
|
2025
Q1 | $455K | Sell |
204,253
-76,780
| -27% | -$171K | ﹤0.01% | 4078 |
|
|
2024
Q4 | $823K | Sell |
281,033
-74,714
| -21% | -$219K | ﹤0.01% | 3906 |
|
|
2024
Q3 | $925K | Buy |
355,747
+21,483
| +6% | +$55.9K | ﹤0.01% | 3685 |
|
|
2024
Q2 | $989K | Sell |
334,264
-36,501
| -10% | -$108K | ﹤0.01% | 3519 |
|
|
2024
Q1 | $1.68M | Sell |
370,765
-38,494
| -9% | -$174K | ﹤0.01% | 3262 |
|
|
2023
Q4 | $2.34M | Sell |
409,259
-127,035
| -24% | -$725K | ﹤0.01% | 3049 |
|
|
2023
Q3 | $2.47M | Buy |
536,294
+61,563
| +13% | +$283K | ﹤0.01% | 2884 |
|
|
2023
Q2 | $3.07M | Sell |
474,731
-236,555
| -33% | -$1.53M | ﹤0.01% | 2792 |
|
|
2023
Q1 | $5.36M | Buy |
711,286
+118,102
| +20% | +$890K | ﹤0.01% | 2395 |
|
|
2022
Q4 | $6.01M | Buy |
593,184
+93,054
| +19% | +$943K | ﹤0.01% | 2255 |
|
|
2022
Q3 | $4.95M | Buy |
500,130
+90,026
| +22% | +$890K | ﹤0.01% | 2345 |
|
|
2022
Q2 | $4.37M | Buy |
410,104
+259,222
| +172% | +$2.76M | ﹤0.01% | 2484 |
|
|
2022
Q1 | $1.47M | Buy |
150,882
+68,844
| +84% | +$671K | ﹤0.01% | 3380 |
|
|
2021
Q4 | $1.17M | Buy |
+82,038
| New | +$1.17M | ﹤0.01% | 3570 |
|